Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitorsDiabetologia 2022 Dec 01;65(12)2032-2043, DS Lin, AL Yu, HY Lo, CW Lien, JK Lee, WJ Chen
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.